{"transactions":[{"id":4635609,"issuer":{"id":6202,"kind":"organization","name":"Aeluma, Inc.","symbol":"ALMU"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-02T05:31:24.000Z","date":"2026-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":5697,"price":12.36,"value":70414.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 41,250 additional shares issuable upon vesting and settlement of existing RSUs that were previously reported in Table II."}],"balance_after":67781,"source":{"system":"sec-edgar","filing":"0001822991-26-000005","document":"form4-10022026_011020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822991/000182299126000005/form4-10022026_011020.xml","form_type":"4"}},{"id":4625804,"issuer":{"id":6202,"kind":"organization","name":"Aeluma, Inc.","symbol":"ALMU"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-23T23:18:19.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":37568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock options scheduled to vest with respect to 25% of the shares on first anniversary of the grant date, and thereafter in 36 substantially equivalent increments on each monthly anniversary of the grant date."}],"balance_after":37568,"derivative":{"exercise_price":13.61,"expiration_date":"2036-09-21","underlying":"Common Stock","underlying_shares":37568},"source":{"system":"sec-edgar","filing":"0001822991-26-000003","document":"form4-09232026_110915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1828805/000182299126000003/form4-09232026_110915.xml","form_type":"4"}},{"id":4625803,"issuer":{"id":6202,"kind":"organization","name":"Aeluma, Inc.","symbol":"ALMU"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-23T23:18:19.000Z","date":"2026-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1450,"price":13.61,"value":19734.5,"ownership":{"direct":true},"balance_after":18478,"source":{"system":"sec-edgar","filing":"0001822991-26-000003","document":"form4-09232026_110915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828805/000182299126000003/form4-09232026_110915.xml","form_type":"4"}},{"id":4625802,"issuer":{"id":6202,"kind":"organization","name":"Aeluma, Inc.","symbol":"ALMU"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-23T23:18:19.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":4042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock award in lieu of cash bonus."}],"balance_after":19928,"source":{"system":"sec-edgar","filing":"0001822991-26-000003","document":"form4-09232026_110915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828805/000182299126000003/form4-09232026_110915.xml","form_type":"4"}},{"id":4625801,"issuer":{"id":6202,"kind":"organization","name":"Aeluma, Inc.","symbol":"ALMU"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-23T23:18:19.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":15886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") scheduled to vest and settle into an equal number of shares of common stock with respect to 25% of the shares on September 30, 2027 and thereafter in 12 substantially equivalent quarterly increments on the last day of each calendar quarter."}],"balance_after":15886,"source":{"system":"sec-edgar","filing":"0001822991-26-000003","document":"form4-09232026_110915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828805/000182299126000003/form4-09232026_110915.xml","form_type":"4"}},{"id":1891348,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T22:22:21.000Z","date":"2023-05-12","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.6683,"value":33415.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6682 to $0.6683, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":281373,"source":{"system":"sec-edgar","filing":"0001411690-23-000031","document":"wf-form4_168427572747814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000031/wf-form4_168427572747814.xml","form_type":"4"}},{"id":2007295,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-18T00:20:45.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":490000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":490000,"derivative":{"exercise_price":1.63,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":490000},"source":{"system":"sec-edgar","filing":"0001209191-23-010918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010918/doc4.xml","form_type":"4"}},{"id":2007294,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-18T00:20:45.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,285 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2022 and 2,509 shares acquired under the ESPP on December 10, 2022."}],"balance_after":231373,"source":{"system":"sec-edgar","filing":"0001209191-23-010918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010918/doc4.xml","form_type":"4"}},{"id":2270173,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-17T01:31:58.000Z","date":"2022-05-13","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person."}],"balance_after":117500,"derivative":{"exercise_price":0.56,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-029459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122029459/doc4.xml","form_type":"4"}},{"id":2270172,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-17T01:31:58.000Z","date":"2022-05-13","kind":"exercise","acquired":true,"shares":60000,"price":0.56,"value":33600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,139 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2021 and 2,940 shares acquired under the ESPP on December 10, 2021."}],"balance_after":121579,"source":{"system":"sec-edgar","filing":"0001209191-22-029459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122029459/doc4.xml","form_type":"4"}},{"id":2394253,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-16T02:08:55.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":550000,"derivative":{"exercise_price":2.18,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001209191-22-010054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122010054/doc4.xml","form_type":"4"}},{"id":2497585,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-23T11:00:24.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person."}],"balance_after":177500,"derivative":{"exercise_price":0.56,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-21-066283","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121066283/doc4.xml","form_type":"4"}},{"id":2497584,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-23T11:00:24.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":22500,"price":0.56,"value":12600.0,"ownership":{"direct":true},"balance_after":55500,"source":{"system":"sec-edgar","filing":"0001209191-21-066283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121066283/doc4.xml","form_type":"4"}},{"id":2693074,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-27T20:36:14.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person."}],"balance_after":200000,"derivative":{"exercise_price":0.56,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-036254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121036254/doc4.xml","form_type":"4"}},{"id":2693073,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-27T20:36:14.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":25000,"price":0.56,"value":14000.0,"ownership":{"direct":true},"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001209191-21-036254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121036254/doc4.xml","form_type":"4"}},{"id":2760909,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T22:33:12.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of April 1, 2021 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":275000,"derivative":{"exercise_price":7.83,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-21-024790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121024790/doc4.xml","form_type":"4"}},{"id":2897563,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-25T21:24:25.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":8000,"price":6,"value":48000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired from the Issuer pursuant to an Underwriting Agreement dated January 20, 2021 with a closing date of January 22, 2021. The Underwriting Agreement and the issuance of the securities thereunder was approved by the Issuer's Board of Directors."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-21-005082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121005082/doc4.xml","form_type":"4"}},{"id":3039002,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T16:53:07.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person."}],"balance_after":225000,"derivative":{"exercise_price":0.56,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-20-049303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919120049303/doc4.xml","form_type":"4"}},{"id":3039001,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T16:53:07.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on September 1, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such applicable vesting date and the terms of the Issuer's 2020 Inducement Plan, subject to acceleration of vesting as provided for in that certain Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person."}],"balance_after":350000,"derivative":{"exercise_price":0.56,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-20-049303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919120049303/doc4.xml","form_type":"4"}}]}